1887

Abstract

The mechanisms of Usutu virus (USUV) pathogenesis are largely unknown. The aim of this study was to evaluate the sensitivity of USUV to interferon (IFN) and the capacity of USUV to stimulate IFN production. Initial experiments were conducted to characterize the susceptibility of human cell lines to USUV infection and to evaluate the single-growth cycle replication curve of USUV. Results indicate that USUV is able to infect a variety of human cell lines, completing the replication cycle in Hep-2 and Vero cells within 48 h. Pre-treatment of cells with types I and III IFNs significantly inhibited the replication of USUV. However, the inhibitory effects of IFNs were considerably less if IFN was added after viral infection had been initiated. Also, USUV weakly induced types I and III IFNs.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.046433-0
2013-04-01
2019-10-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/94/4/789.html?itemId=/content/journal/jgv/10.1099/vir.0.046433-0&mimeType=html&fmt=ahah

References

  1. Anderson J. F., Rahal J. J.. ( 2002;). Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. . Emerg Infect Dis 8:, 107–108. [CrossRef][PubMed]
    [Google Scholar]
  2. Ank N., West H., Bartholdy C., Eriksson K., Thomsen A. R., Paludan S. R.. ( 2006;). Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. . J Virol 80:, 4501–4509. [CrossRef][PubMed]
    [Google Scholar]
  3. Bakonyi T., Lussy H., Weissenböck H., Hornyák A., Nowotny N.. ( 2005;). In vitro host-cell susceptibility to Usutu virus. . Emerg Infect Dis 11:, 298–301. [CrossRef][PubMed]
    [Google Scholar]
  4. Brass A. L., Huang I. C., Benita Y., John S. P., Krishnan M. N., Feeley E. M., Ryan B. J., Weyer J. L., van der Weyden L.. & other authors ( 2009;). The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. . Cell 139:, 1243–1254. [CrossRef][PubMed]
    [Google Scholar]
  5. Cavrini F., Gaibani P., Longo G., Pierro A. M., Rossini G., Bonilauri P., Gerundi G. E., Di Benedetto F., Pasetto A.. & other authors ( 2009;). Usutu virus infection in a patient who underwent orthotropic liver transplantation, Italy, August–September 2009. . Euro Surveill 14:, 50.[PubMed]
    [Google Scholar]
  6. Cavrini F., Pepa M. E. D., Gaibani P., Pierro A. M., Rossini G., Landini M. P., Sambri V.. ( 2011;). A rapid and specific real-time RT-PCR assay to identify Usutu virus in human plasma, serum, and cerebrospinal fluid. . J Clin Virol 50:, 221–223. [CrossRef][PubMed]
    [Google Scholar]
  7. Chvala S., Bakonyi T., Bukovsky C., Meister T., Brugger K., Rubel F., Nowotny N., Weissenböck H.. ( 2007;). Monitoring of Usutu virus activity and spread by using dead bird surveillance in Austria, 2003–2005. . Vet Microbiol 122:, 237–245. [CrossRef][PubMed]
    [Google Scholar]
  8. Colpitts T. M., Barthel S., Wang P., Fikrig E.. ( 2011;). Dengue virus capsid protein binds core histones and inhibits nucleosome formation in human liver cells. . PLoS ONE 6:, e24365. [CrossRef][PubMed]
    [Google Scholar]
  9. Daffis S., Suthar M. S., Gale M. Jr, Diamond M. S.. ( 2009;). Measure and countermeasure: type I IFN (IFN-alpha/beta) antiviral response against West Nile virus. . J Innate Immun 1:, 435–445. [CrossRef][PubMed]
    [Google Scholar]
  10. Diamond M. S., Roberts T. G., Edgil D., Lu B., Ernst J., Harris E.. ( 2000;). Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. . J Virol 74:, 4957–4966. [CrossRef][PubMed]
    [Google Scholar]
  11. Faul E. J., Lyles D. S., Schnell M. J.. ( 2009;). Interferon response and viral evasion by members of the family Rhabdoviridae. . Viruses 1:, 832–851. [CrossRef][PubMed]
    [Google Scholar]
  12. Gaibani P., Pierro A., Alicino R., Rossini G., Cavrini F., Landini M. P., Sambri V.. ( 2012;). Detection of Usutu-virus-specific IgG in blood donors from northern Italy. . Vector Borne Zoonotic Dis 12:, 431–433. [CrossRef][PubMed]
    [Google Scholar]
  13. Hoenen A., Liu W., Kochs G., Khromykh A. A., Mackenzie J. M.. ( 2007;). West Nile virus-induced cytoplasmic membrane structures provide partial protection against the interferon-induced antiviral MxA protein. . J Gen Virol 88:, 3013–3017. [CrossRef][PubMed]
    [Google Scholar]
  14. Kelly C., Klenerman P., Barnes E.. ( 2011;). Interferon lambdas: the next cytokine storm. . Gut 60:, 1284–1293. [CrossRef][PubMed]
    [Google Scholar]
  15. Marcello T., Grakoui A., Barba-Spaeth G., Machlin E. S., Kotenko S. V., MacDonald M. R., Rice C. M.. ( 2006;). Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. . Gastroenterology 131:, 1887–1898. [CrossRef][PubMed]
    [Google Scholar]
  16. Meager A., Visvalingam K., Dilger P., Bryan D., Wadhwa M.. ( 2005;). Biological activity of interleukins-28 and -29: comparison with type I interferons. . Cytokine 31:, 109–118. [CrossRef][PubMed]
    [Google Scholar]
  17. Morrison J., Aguirre S., Fernandez-Sesma A.. ( 2012;). Innate immunity evasion by Dengue virus. . Viruses 4:, 397–413. [CrossRef][PubMed]
    [Google Scholar]
  18. Pastorino B., Boucomont-Chapeaublanc E., Peyrefitte C. N., Belghazi M., Fusaï T., Rogier C., Tolou H. J., Almeras L.. ( 2009;). Identification of cellular proteome modifications in response to West Nile virus infection. . Mol Cell Proteomics 8:, 1623–1637. [CrossRef][PubMed]
    [Google Scholar]
  19. Pecorari M., Longo G., Gennari W., Grottola A., Sabbatini A., Tagliazucchi S., Savini G., Monaco F., Simone M.. & other authors ( 2009;). First human case of Usutu virus neuroinvasive infection, Italy, August–September 2009. . Euro Surveill 14:, 50.[PubMed]
    [Google Scholar]
  20. Reed L. J., Muench H.. ( 1938;). A simple method of estimating fifty percent endpoints. . Am J Hyg 27:, 493–497.
    [Google Scholar]
  21. Samuel M. A., Diamond M. S.. ( 2005;). Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. . J Virol 79:, 13350–13361. [CrossRef][PubMed]
    [Google Scholar]
  22. Sangiambut S., Keelapang P., Aaskov J., Puttikhunt C., Kasinrerk W., Malasit P., Sittisombut N.. ( 2008;). Multiple regions in dengue virus capsid protein contribute to nuclear localization during virus infection. . J Gen Virol 89:, 1254–1264. [CrossRef][PubMed]
    [Google Scholar]
  23. Scagnolari C., Vicenzi E., Bellomi F., Stillitano M. G., Pinna D., Poli G., Clementi M., Dianzani F., Antonelli G.. ( 2004;). Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons. . Antivir Ther 9:, 1003–1011.[PubMed]
    [Google Scholar]
  24. Scagnolari C., Trombetti S., Cicetti S., Antonelli S., Selvaggi C., Perrone L., Visca M., Romano S., Antonelli G.. ( 2008;). Severe acute respiratory syndrome coronavirus elicits a weak interferon response compared to traditional interferon-inducing viruses. . Intervirology 51:, 217–223. [CrossRef][PubMed]
    [Google Scholar]
  25. Scagnolari C., Trombetti S., Selvaggi C., Carbone T., Monteleone K., Spano L., Di Marco P., Pierangeli A., Maggi F.. & other authors ( 2011;). In vitro sensitivity of human metapneumovirus to type I interferons. . Viral Immunol 24:, 159–164. [CrossRef][PubMed]
    [Google Scholar]
  26. Su H. L., Liao C. L., Lin Y. L.. ( 2002;). Japanese encephalitis virus infection initiates endoplasmic reticulum stress and an unfolded protein response. . J Virol 76:, 4162–4171. [CrossRef][PubMed]
    [Google Scholar]
  27. Tu Y. C., Yu C. Y., Liang J. J., Lin E., Liao C. L., Lin Y. L.. ( 2012;). Blocking double-stranded RNA-activated protein kinase PKR by Japanese encephalitis virus nonstructural protein 2A. . J Virol 86:, 10347–10358. [CrossRef][PubMed]
    [Google Scholar]
  28. Vazquez A., Jimenez-Clavero M., Franco L., Donoso-Mantke O., Sambri V., Niedrig M., Zeller H., Tenorio A.. ( 2011;). Usutu virus: potential risk of human disease in Europe. . Euro Surveill 16:, 31.[PubMed]
    [Google Scholar]
  29. Weissenböck H., Kolodziejek J., Url A., Lussy H., Rebel-Bauder B., Nowotny N.. ( 2002;). Emergence of Usutu virus, an African mosquito-borne flavivirus of the Japanese encephalitis virus group, central Europe. . Emerg Infect Dis 8:, 652–656. [CrossRef][PubMed]
    [Google Scholar]
  30. Weissenböck H., Kolodziejek J., Fragner K., Kuhn R., Pfeffer M., Nowotny N.. ( 2003;). Usutu virus activity in Austria, 2001–2002. . Microbes Infect 5:, 1132–1136. [CrossRef][PubMed]
    [Google Scholar]
  31. Westaway E. G., Khromykh A. A., Kenney M. T., Mackenzie J. M., Jones M. K.. ( 1997;). Proteins C and NS4B of the flavivirus Kunjin translocate independently into the nucleus. . Virology 234:, 31–41. [CrossRef][PubMed]
    [Google Scholar]
  32. Yu C. Y., Hsu Y. W., Liao C. L., Lin Y. L.. ( 2006;). Flavivirus infection activates the XBP1 pathway of the unfolded protein response to cope with endoplasmic reticulum stress. . J Virol 80:, 11868–11880. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.046433-0
Loading
/content/journal/jgv/10.1099/vir.0.046433-0
Loading

Data & Media loading...

Supplements

Supplementary Material 

PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error